Literature DB >> 24646107

Relationship between adiponectin, leptin, IGF-1 and total lipid peroxides plasma concentrations in patients with systemic sclerosis: possible role in disease development.

Katarzyna Winsz-Szczotka1, Kornelia Kuźnik-Trocha1, Katarzyna Komosińska-Vassev1, Eugeniusz Kucharz2, Anna Kotulska2, Krystyna Olczyk1.   

Abstract

AIM: The relationship between adiponectin, leptin, insulin-like growth factor-1 (IGF-1) and total lipid peroxide (TLP) concentrations, and its possible role in the development of diffuse cutaneous systemic sclerosis (dcSSc), were evaluated in this study. METHODS,
RESULTS: Plasma adipokines and IGF-1 levels were determined using the enzyme-linked immunosorbent assay method, whereas TLP levels were determined using a photometric test, in 36 dcSSc patients and 40 healthy controls matched by age, sex and body mass index (BMI). Plasma levels of adipokines were significantly lowered, while TLP and IGF-1 were increased in dcSSc patients compared to controls. Adiponectin correlated significantly with leptin (r = 0.44), TLP (r = -0.54), CRP (r = -0.47), erythrocyte sedimentation rate (ESR) (r = -0.40) and duration of disease (r = -0.44). A significant relationship was found between leptinemia and IGF-1 (r = -0.40), TLP (r = 0.44), duration of disease (r = -0.38) and BMI (r = 0.65). TLP correlated with IGF-1 (r = -0.43), C-reactive protein (r = 0.47), ESR (r = 0.49) and duration of disease (r = 0.46), while IGF-1 correlated with ESR (r = -0.40).
CONCLUSIONS: Adipose tissue may play a complex role in the development of dcSSc, affecting both the metabolic state of the organism, as well as free radical-induced connective tissue degradation. Although, leptin seems to exert a pro-oxidative effect and both adiponectin and IGF-1 appear to prevent free radical damage, confirmation of the above effects requires further research.
© 2014 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  IGF-1; adiponectin; leptin; systemic sclerosis; total lipid peroxides

Mesh:

Substances:

Year:  2014        PMID: 24646107     DOI: 10.1111/1756-185X.12332

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  7 in total

1.  Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis.

Authors:  Y H Lee; G G Song
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

2.  No Association between Vitiligo and Obesity: A Case-Control Study.

Authors:  Federica Dragoni; Rossana Conti; Simone Cazzaniga; Roberta Colucci; Lisa Pisaneschi; Luigi Naldi; Silvia Moretti
Journal:  Med Princ Pract       Date:  2017-09-12       Impact factor: 1.927

3.  Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP.

Authors:  Annette Masuch; Maik Pietzner; Martin Bahls; Kathrin Budde; Gabi Kastenmüller; Stephanie Zylla; Anna Artati; Jerzy Adamski; Henry Völzke; Marcus Dörr; Stephan B Felix; Matthias Nauck; Nele Friedrich
Journal:  Cardiovasc Diabetol       Date:  2018-08-28       Impact factor: 9.951

4.  Clinical associations of serum leptin and leptin/adiponectin ratio in systemic sclerosis.

Authors:  Małgorzata Michalska-Jakubus; Karolina Sawicka; Emilia Potembska; Małgorzata Kowal; Dorota Krasowska
Journal:  Postepy Dermatol Alergol       Date:  2018-05-16       Impact factor: 1.837

5.  The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis.

Authors:  Gianluca Bagnato; Erika Pigatto; Alessandra Bitto; Gabriele Pizzino; Natasha Irrera; Giuseppina Abignano; Antonino Ferrera; Davide Sciortino; Michelle Wilson; Francesco Squadrito; Maya H Buch; Paul Emery; Elisabetta Zanatta; Sebastiano Gangemi; Antonino Saitta; Franco Cozzi; William Neal Roberts; Francesco Del Galdo
Journal:  Front Med (Lausanne)       Date:  2021-03-17

6.  Identification of Potential ceRNA Network and Patterns of Immune Cell Infiltration in Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Qiuhong Wu; Yang Liu; Yan Xie; Shixiong Wei; Yi Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-17

7.  Body mass index and adipokines/cytokines dysregulation in systemic sclerosis.

Authors:  Florenzo Iannone; Emanuela Praino; Cinzia Rotondo; Dorotea Natuzzi; Rita Bizzoca; Nunzia Lacarpia; Marco Fornaro; Fabio Cacciapaglia
Journal:  Clin Exp Immunol       Date:  2021-08-16       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.